Showing results (121-130 of 317) with videos related to
Sort By:
Pageof 32
International Immunology|September 1, 1996
Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigensC Farina, P van der Bruggen, P Boël, et al.Tissue Antigens|July 24, 2002
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clonesM Sensi, S Pellegatta, C Vegetti, et al.Methods in Molecular Medicine|February 11, 2012
Gene therapy in melanomaG Parmiani, F Arienti, C Melani, et al.Melanoma Research|February 1, 1994
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanomaR Lupetti, M Sensi, R Mortarini, et al.International Journal of Cancer|May 1, 1994
Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptorsM Rodolfo, C Castelli, C Bassi, et al.Cancer Research|January 1, 1986
Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesionsD Taramelli, G Fossati, A Mazzocchi, et al.Journal of Cellular Physiology|May 6, 1999
The overlooked "nonclassical" functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cellsM Altomonte, C Pucillo, M MaioClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancersC Gambacorti-Passerini, C Bertazzoli, S Dermime, et al.Tumori|January 16, 1998
HLA binding characteristics and generation of cytotoxic lymphocytes against peptides derived from oncogenic proteinsC Bertazzoli, E Marchesi, S Dermime, et al.The Journal of Clinical Investigation|June 24, 1998
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanomaD J Hicklin, Z Wang, F Arienti, et al.Pageof 32